Liraglutide and Dulaglutide Have Comparable HbA1c Reduction in Emirati Patients with T2DM

Journals Menu

Follow SCIRP

ISSN Print: 2165-7424
ISSN Online: 2165-7432
www.scirp.org/journal/ojemd
E-mail: ojemd@scirp.org

Citations h5-index & Ranking*

"Liraglutide and Dulaglutide Have Comparable HbA1c Reduction in Emirati Patients with T2DM"
written by Aml Mohamed Nada, Mariam Adel Younan,
published by Open Journal of Endocrine and Metabolic Diseases, Vol.11 No.4, 2021

has been cited by the following article(s):

No relevant information.

Follow SCIRP